ISRG vs. DXCM, GOOG, HSIC, IDXX, ELV, EW, ITGR, JNJ, MDT, and SYK
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include DexCom (DXCM), Alphabet (GOOG), Henry Schein (HSIC), IDEXX Laboratories (IDXX), Elevance Health (ELV), Edwards Lifesciences (EW), Integer (ITGR), Johnson & Johnson (JNJ), Medtronic (MDT), and Stryker (SYK).
Intuitive Surgical vs. Its Competitors
DexCom (NASDAQ:DXCM) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.
DexCom has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.
Intuitive Surgical has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Intuitive Surgical had 33 more articles in the media than DexCom. MarketBeat recorded 56 mentions for Intuitive Surgical and 23 mentions for DexCom. Intuitive Surgical's average media sentiment score of 1.21 beat DexCom's score of 0.99 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Intuitive Surgical has a net margin of 28.51% compared to DexCom's net margin of 13.29%. DexCom's return on equity of 30.41% beat Intuitive Surgical's return on equity.
97.8% of DexCom shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 0.7% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
DexCom currently has a consensus target price of $99.89, suggesting a potential upside of 27.42%. Intuitive Surgical has a consensus target price of $595.95, suggesting a potential upside of 27.47%. Given Intuitive Surgical's higher probable upside, analysts plainly believe Intuitive Surgical is more favorable than DexCom.
Summary
Intuitive Surgical beats DexCom on 12 of the 17 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Intuitive Surgical Competitors List
Related Companies and Tools
This page (NASDAQ:ISRG) was last updated on 9/9/2025 by MarketBeat.com Staff